Effect of homocysteine-induced oxidative stress on endothelial function in coronary slow-flow

Halil Tanriverdi1, Harun Evrengul, Yasar Enli

  • 1Department of Cardiology, Pamukkale University School of Medicine, Denizli, Turkey. htanriverdi@pau.edu.tr

Cardiology
|February 1, 2007
PubMed

Insights

Patients with coronary slow-flow (CSF) phenomenon exhibit elevated plasma homocysteine (Hcy) levels and increased oxidative stress. These factors are linked to impaired endothelial function, a key finding in CSF.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biochemistry

Background:

  • Coronary slow-flow (CSF) phenomenon involves delayed coronary artery opacification without obstructive lesions.
  • The exact cause of CSF is unknown, but endothelial dysfunction and elevated homocysteine (Hcy) are suspected contributors.
  • Oxidative stress may play a role in the pathogenesis of CSF.

Purpose of the Study:

  • To investigate endothelial function in patients with CSF.
  • To examine the relationship between Hcy levels, oxidative stress markers, and endothelial function in CSF patients.
  • To compare these parameters between CSF patients and healthy controls.

Main Methods:

  • 44 patients with angiographically confirmed CSF and 44 controls were studied.
  • Coronary flow was assessed using the TIMI frame count.
  • Endothelial function was evaluated via flow-mediated dilation (FMD) using high-frequency ultrasound.
  • Blood samples were analyzed for homocysteine (Hcy), superoxide dismutase (SOD), reduced glutathione (GSH), and malondialdehyde (MDA).

Main Results:

  • CSF patients had significantly higher plasma Hcy levels (12.2 ± 4.9 vs. 8.5 ± 2.8 μmol/l, p=0.0001).
  • Endothelial-dependent FMD was significantly reduced in CSF patients (4.98 ± 1.1% vs. 7.87 ± 2.0%, p=0.0001).
  • CSF patients showed reduced GSH and elevated SOD and MDA, indicating increased oxidative stress.
  • Plasma Hcy positively correlated with TIMI frame count and negatively with FMD.

Conclusions:

  • Patients with CSF demonstrate elevated Hcy levels and markers of oxidative stress.
  • Impaired endothelial cell function is a significant finding in individuals with CSF.
  • Hcy and oxidative stress are implicated in the pathophysiology of the coronary slow-flow phenomenon.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...